Market Outlook
The global Colorectal Cancer Molecular Diagnostics market size was valued at USD 617.9 million in 2022 and is forecast to a readjusted size of USD 1504.1 million by 2029 with a CAGR of 13.6% during review period.
This report is a detailed and comprehensive analysis for global Colorectal Cancer Molecular Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe. In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
Key Features:
Global Colorectal Cancer Molecular Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Colorectal Cancer Molecular Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Colorectal Cancer Molecular Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Colorectal Cancer Molecular Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colorectal Cancer Molecular Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colorectal Cancer Molecular Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Segmentation By Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Segmentation By Application
Hospital
Third-Party Testing Agency
Others
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Colorectal Cancer Molecular Diagnostics Market in 2025?
The increasing adoption of personalized medicine and the growing emphasis on early diagnosis are key strengths. Technological advancements in molecular diagnostic tools enhance accuracy and sensitivity, making early detection more reliable. Additionally, rising awareness about colorectal cancer and its prevention drives demand for molecular diagnostics.
What are the weaknesses of the Colorectal Cancer Molecular Diagnostics Market in 2025?
The high cost of advanced molecular diagnostic tests may limit accessibility in lower-income regions. Regulatory hurdles and the need for extensive clinical validation can delay the adoption of new technologies. Furthermore, there may be challenges in the standardization of diagnostic protocols across diverse healthcare settings.
What are the opportunities in the Colorectal Cancer Molecular Diagnostics Market in 2025?
There are significant opportunities for growth in emerging markets, where awareness and healthcare infrastructure are improving. The integration of artificial intelligence and machine learning to enhance diagnostic accuracy could further revolutionize the market. Partnerships between biotech firms and healthcare providers also present new avenues for expanding the market.
What are the threats to the Colorectal Cancer Molecular Diagnostics Market in 2025?
Competitive pressures from traditional diagnostic methods and the emergence of alternative technologies, such as liquid biopsy, pose a threat to molecular diagnostics. Moreover, the regulatory environment can be unpredictable, and any changes in reimbursement policies may impact market growth. Economic downturns could also reduce healthcare spending, slowing market adoption.
Market PESTEL Analysis
What are the political factors influencing the Colorectal Cancer Molecular Diagnostics Market in 2025?
Government policies and healthcare regulations play a significant role in shaping market dynamics. Changes in reimbursement policies, funding for cancer research, and government initiatives promoting early cancer detection can either drive or restrict market growth. Political stability in key regions is also critical for the smooth operation of healthcare systems.
How do economic factors impact the Colorectal Cancer Molecular Diagnostics Market in 2025?
Economic conditions influence healthcare spending, affecting demand for advanced diagnostic tools. In economically prosperous regions, the market may experience growth due to increased investment in healthcare infrastructure and molecular diagnostics. On the other hand, economic downturns can lead to budget cuts in healthcare, which may slow down market expansion, especially in developing markets.
What social factors are relevant to the Colorectal Cancer Molecular Diagnostics Market in 2025?
Increasing awareness about colorectal cancer and the importance of early detection is a major social driver for the market. Changing lifestyles, including poor diets and sedentary behavior, contribute to the rising incidence of colorectal cancer, thus increasing demand for early diagnostic solutions. Social stigmas surrounding cancer diagnosis and treatment could affect patient participation in screening programs.
How does technology impact the Colorectal Cancer Molecular Diagnostics Market in 2025?
Technological advancements, particularly in genomics, biomarkers, and next-generation sequencing, are revolutionizing molecular diagnostics. These technologies enable earlier and more accurate detection of colorectal cancer, improving patient outcomes. Artificial intelligence and machine learning integration into diagnostic tools further enhance precision and efficiency, driving market growth.
What environmental factors affect the Colorectal Cancer Molecular Diagnostics Market in 2025?
Sustainability concerns around medical waste, such as single-use diagnostic tools, could impact the development and adoption of molecular diagnostics. However, increasing focus on eco-friendly production methods and reducing the environmental footprint of medical technologies could benefit the market. Environmental policies may also encourage greener practices in the healthcare sector.
What legal factors influence the Colorectal Cancer Molecular Diagnostics Market in 2025?
Legal regulations regarding medical device approval, patent laws, and data privacy laws (especially in relation to patient genetic information) can significantly impact the market. Stringent approval processes and evolving legal frameworks surrounding molecular diagnostics require continuous compliance, which could slow down innovation and market entry.
Market SIPOC Analysis
Who are the suppliers in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Suppliers include biotech companies, pharmaceutical firms, diagnostic laboratories, and manufacturers of diagnostic equipment and reagents. These suppliers provide essential raw materials, technologies, and innovations used in molecular diagnostic tests for colorectal cancer.
What are the inputs required in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Inputs involve raw materials such as genetic materials, biomarkers, reagents, and testing kits. Advanced technologies like next-generation sequencing (NGS) platforms, artificial intelligence software, and laboratory equipment are also critical inputs for developing accurate diagnostic tools.
What are the processes involved in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Processes include the research and development of molecular diagnostic tests, clinical validation of diagnostic technologies, regulatory approval, manufacturing, and distribution of diagnostic kits. Additionally, healthcare providers and diagnostic labs play a role in the execution of testing and delivering results.
Who are the customers in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Customers include hospitals, diagnostic laboratories, healthcare providers, and clinicians who use molecular diagnostic tests for colorectal cancer. Additionally, patients and healthcare systems that require these diagnostics for early detection and personalized treatment represent the final customer segment.
What are the outputs of the Colorectal Cancer Molecular Diagnostics Market in 2025?
The outputs include molecular diagnostic tests and screening kits, diagnostic reports, and personalized treatment recommendations. These outputs enable healthcare providers to detect colorectal cancer early, monitor treatment efficacy, and improve patient outcomes.
Market Porter's Five Forces
How intense is the threat of new entrants in the Colorectal Cancer Molecular Diagnostics Market in 2025?
The threat of new entrants is moderate. While the market is attractive due to growing demand for early cancer detection, high barriers to entry such as regulatory approval, expensive R&D, and the need for advanced technological capabilities limit the number of new players. However, smaller biotech firms with innovative solutions may still find ways to enter.
What is the bargaining power of suppliers in the Colorectal Cancer Molecular Diagnostics Market in 2025?
The bargaining power of suppliers is moderate to high. Suppliers of critical components, such as genetic materials, biomarkers, and diagnostic platforms, hold significant power due to the specialized nature of these inputs. However, with increasing competition and innovation in the supply chain, the power of suppliers could decrease over time.
What is the bargaining power of buyers in the Colorectal Cancer Molecular Diagnostics Market in 2025?
The bargaining power of buyers is moderate. While healthcare providers and laboratories have some leverage in choosing diagnostic solutions, the high level of specialization and differentiation in molecular diagnostics reduces their ability to drive prices down. Moreover, increasing awareness of the importance of accurate and timely diagnostics strengthens the demand for quality over price.
How intense is the threat of substitute products in the Colorectal Cancer Molecular Diagnostics Market in 2025?
The threat of substitutes is moderate. Traditional diagnostic methods, such as colonoscopies, and newer technologies like liquid biopsy could serve as alternatives. However, molecular diagnostics offer greater precision and personalized treatment options, which makes them more attractive in certain patient populations, reducing the threat of substitutes.
How competitive is the Colorectal Cancer Molecular Diagnostics Market in 2025?
The competition in the Colorectal Cancer Molecular Diagnostics Market is high. There are multiple established players, including diagnostic labs and biotech firms, offering a range of molecular diagnostic tests. These companies constantly innovate to enhance accuracy and speed, making the market highly competitive. Additionally, the potential for high returns in personalized medicine attracts both new and established firms.
Market Upstream Analysis
What are the key raw materials involved in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Key raw materials include genetic materials, reagents, biomarkers, and diagnostic kits. These materials are essential for developing accurate molecular tests that can detect colorectal cancer at an early stage. Additionally, platforms for next-generation sequencing (NGS) and various laboratory consumables are critical in this upstream process.
Who are the primary suppliers for these raw materials in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Primary suppliers are biotech companies, pharmaceutical firms, and specialized manufacturers of diagnostic reagents, kits, and NGS platforms. These suppliers provide the technology, chemicals, and biological materials necessary to develop and implement molecular diagnostic tests for colorectal cancer.
What technological developments impact the upstream process in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Technological advancements in genomics, artificial intelligence, and next-generation sequencing platforms are reshaping the upstream process. Innovations in precision medicine and more efficient diagnostic technologies allow for faster and more accurate tests, reducing time and cost in the development of colorectal cancer diagnostic tools.
What regulatory challenges affect the upstream process in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Regulatory challenges such as lengthy approval processes and compliance with international standards (e.g., FDA or EMA) can delay product development. Additionally, ongoing changes in healthcare regulations, such as reimbursement policies, can impact the accessibility of these raw materials and diagnostic solutions, affecting market dynamics.
What is the role of R&D in the upstream process of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Research and development play a crucial role in the upstream process by driving innovation in molecular diagnostic technologies. R&D efforts focus on identifying new biomarkers, improving the sensitivity and accuracy of diagnostic tests, and enhancing the overall efficiency of diagnostic platforms, which ultimately influences the success of the market.
Market Midstream Analysis
What are the key processes involved in the midstream phase of the Colorectal Cancer Molecular Diagnostics Market in 2025?
The midstream phase involves the manufacturing, packaging, and distribution of molecular diagnostic kits, reagents, and testing platforms. It also includes clinical validation, regulatory approvals, and ensuring compliance with standards to bring products to market. Additionally, the establishment of distribution networks and partnerships with diagnostic laboratories is crucial.
Who are the main players involved in the midstream phase of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Key players in the midstream phase include diagnostic manufacturers, biotech companies, and contract manufacturers. These entities are responsible for scaling up production, ensuring product quality, and distributing diagnostic tools to hospitals, clinics, and diagnostic laboratories. Partnerships with research institutions also play a significant role in clinical validation.
How does technology influence the midstream process in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Technology plays a pivotal role in streamlining the manufacturing process by improving the precision and efficiency of diagnostic equipment. Automation in production, coupled with advancements in molecular biology, ensures higher consistency and reliability of tests. Technologies like artificial intelligence (AI) also aid in the validation and quality control of diagnostic kits during this phase.
What are the main challenges in the midstream process of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Challenges include the complexity of scaling up production to meet global demand while maintaining high standards of quality. Regulatory hurdles, such as compliance with varying international guidelines, can delay the distribution process. Additionally, logistical issues related to cold chain requirements for certain diagnostic materials can disrupt timely delivery.
How do partnerships and collaborations impact the midstream phase of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Partnerships between diagnostic manufacturers, healthcare providers, and research institutions are essential for ensuring the rapid clinical validation and distribution of molecular diagnostic tools. These collaborations help in sharing resources, research data, and technologies, which accelerates the development and availability of colorectal cancer diagnostic solutions in the market.
Market Downstream Analysis
What are the key activities in the downstream phase of the Colorectal Cancer Molecular Diagnostics Market in 2025?
The downstream phase involves the use of molecular diagnostic tests by healthcare providers, diagnostic labs, and clinical settings to detect colorectal cancer. This phase also includes patient consultation, result interpretation, and the development of personalized treatment plans based on diagnostic findings. Post-diagnosis monitoring and follow-up testing are also essential components.
Who are the key stakeholders in the downstream phase of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Key stakeholders include hospitals, diagnostic laboratories, oncologists, healthcare providers, and patients. Healthcare providers and laboratories are directly involved in administering and interpreting the tests, while patients are the ultimate recipients of the diagnostic services and treatments. Additionally, insurance companies influence the accessibility of diagnostics through reimbursement policies.
How does technology affect the downstream phase in the Colorectal Cancer Molecular Diagnostics Market in 2025?
Technology impacts the downstream phase by enabling faster, more accurate diagnostic results through advanced molecular technologies like next-generation sequencing (NGS) and artificial intelligence (AI). AI and machine learning can assist in interpreting complex genomic data, ensuring more precise diagnoses and personalized treatment regimens for colorectal cancer patients.
What challenges are faced in the downstream process of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Challenges in the downstream process include ensuring timely access to diagnostic tests, overcoming patient resistance to new diagnostic methods, and managing the costs associated with advanced molecular testing. Additionally, variations in reimbursement policies and healthcare access in different regions can limit widespread adoption of molecular diagnostics.
How do market dynamics affect the downstream phase of the Colorectal Cancer Molecular Diagnostics Market in 2025?
Market dynamics, such as increased awareness of colorectal cancer prevention, the adoption of personalized medicine, and advancements in healthcare infrastructure, drive demand for molecular diagnostics. However, economic factors and the pace of adoption in different regions can create disparities in access to these technologies, influencing market growth and accessibility.
Chapter 1, to describe Colorectal Cancer Molecular Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Colorectal Cancer Molecular Diagnostics, with revenue, gross margin and global market share of Colorectal Cancer Molecular Diagnostics from 2018 to 2023.
Chapter 3, the Colorectal Cancer Molecular Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Colorectal Cancer Molecular Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Molecular Diagnostics.
Chapter 13, to describe Colorectal Cancer Molecular Diagnostics research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Colorectal Cancer Molecular Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Colorectal Cancer Molecular Diagnostics by Type
1.3.1 Overview: Global Colorectal Cancer Molecular Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type in 2022
1.3.3 Polymerase Chain Reaction PCR
1.3.4 Molecular Hybridization
1.3.5 Biochip
1.3.6 Others
1.4 Global Colorectal Cancer Molecular Diagnostics Market by Application
1.4.1 Overview: Global Colorectal Cancer Molecular Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Third-Party Testing Agency
1.4.4 Others
1.5 Global Colorectal Cancer Molecular Diagnostics Market Size & Forecast
1.6 Global Colorectal Cancer Molecular Diagnostics Market Size and Forecast by Region
1.6.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Region, (2018-2029)
1.6.3 North America Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.4 Europe Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.6 South America Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product and Solutions
2.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Colorectal Cancer Molecular Diagnostics Product and Solutions
2.2.4 Abbott Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Recent Developments and Future Plans
2.3 Thermo Fisher
2.3.1 Thermo Fisher Details
2.3.2 Thermo Fisher Major Business
2.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product and Solutions
2.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Recent Developments and Future Plans
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business
2.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Product and Solutions
2.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Qiagen Recent Developments and Future Plans
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Colorectal Cancer Molecular Diagnostics Product and Solutions
2.5.4 Illumina Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Illumina Recent Developments and Future Plans
2.6 Biomerieux
2.6.1 Biomerieux Details
2.6.2 Biomerieux Major Business
2.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Product and Solutions
2.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Biomerieux Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Product and Solutions
2.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Agilent
2.8.1 Agilent Details
2.8.2 Agilent Major Business
2.8.3 Agilent Colorectal Cancer Molecular Diagnostics Product and Solutions
2.8.4 Agilent Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Agilent Recent Developments and Future Plans
2.9 Daangene
2.9.1 Daangene Details
2.9.2 Daangene Major Business
2.9.3 Daangene Colorectal Cancer Molecular Diagnostics Product and Solutions
2.9.4 Daangene Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Daangene Recent Developments and Future Plans
2.10 Amoydx
2.10.1 Amoydx Details
2.10.2 Amoydx Major Business
2.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Product and Solutions
2.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Amoydx Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Colorectal Cancer Molecular Diagnostics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Colorectal Cancer Molecular Diagnostics by Company Revenue
3.2.2 Top 3 Colorectal Cancer Molecular Diagnostics Players Market Share in 2022
3.2.3 Top 6 Colorectal Cancer Molecular Diagnostics Players Market Share in 2022
3.3 Colorectal Cancer Molecular Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Colorectal Cancer Molecular Diagnostics Market: Region Footprint
3.3.2 Colorectal Cancer Molecular Diagnostics Market: Company Product Type Footprint
3.3.3 Colorectal Cancer Molecular Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Colorectal Cancer Molecular Diagnostics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2018-2023)
5.2 Global Colorectal Cancer Molecular Diagnostics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2029)
6.2 North America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2029)
6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
6.3.1 North America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2029)
6.3.2 United States Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
6.3.3 Canada Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
6.3.4 Mexico Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2029)
7.2 Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2029)
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
7.3.1 Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2029)
7.3.2 Germany Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.3 France Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.5 Russia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.6 Italy Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region
8.3.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2018-2029)
8.3.2 China Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.3 Japan Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.4 South Korea Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.5 India Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.7 Australia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2029)
9.2 South America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2029)
9.3 South America Colorectal Cancer Molecular Diagnostics Market Size by Country
9.3.1 South America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2029)
9.3.2 Brazil Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
9.3.3 Argentina Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
10.3.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2029)
10.3.2 Turkey Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
10.3.4 UAE Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Colorectal Cancer Molecular Diagnostics Market Drivers
11.2 Colorectal Cancer Molecular Diagnostics Market Restraints
11.3 Colorectal Cancer Molecular Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Colorectal Cancer Molecular Diagnostics Industry Chain
12.2 Colorectal Cancer Molecular Diagnostics Upstream Analysis
12.3 Colorectal Cancer Molecular Diagnostics Midstream Analysis
12.4 Colorectal Cancer Molecular Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Roche Diagnostics Major Business
Table 7. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 8. Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Diagnostics Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 13. Abbott Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbott Recent Developments and Future Plans
Table 15. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Major Business
Table 17. Thermo Fisher Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 18. Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Recent Developments and Future Plans
Table 20. Qiagen Company Information, Head Office, and Major Competitors
Table 21. Qiagen Major Business
Table 22. Qiagen Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 23. Qiagen Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Qiagen Recent Developments and Future Plans
Table 25. Illumina Company Information, Head Office, and Major Competitors
Table 26. Illumina Major Business
Table 27. Illumina Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 28. Illumina Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Illumina Recent Developments and Future Plans
Table 30. Biomerieux Company Information, Head Office, and Major Competitors
Table 31. Biomerieux Major Business
Table 32. Biomerieux Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 33. Biomerieux Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Biomerieux Recent Developments and Future Plans
Table 35. Bio-Rad Company Information, Head Office, and Major Competitors
Table 36. Bio-Rad Major Business
Table 37. Bio-Rad Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 38. Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Bio-Rad Recent Developments and Future Plans
Table 40. Agilent Company Information, Head Office, and Major Competitors
Table 41. Agilent Major Business
Table 42. Agilent Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 43. Agilent Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Agilent Recent Developments and Future Plans
Table 45. Daangene Company Information, Head Office, and Major Competitors
Table 46. Daangene Major Business
Table 47. Daangene Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 48. Daangene Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Daangene Recent Developments and Future Plans
Table 50. Amoydx Company Information, Head Office, and Major Competitors
Table 51. Amoydx Major Business
Table 52. Amoydx Colorectal Cancer Molecular Diagnostics Product and Solutions
Table 53. Amoydx Colorectal Cancer Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Amoydx Recent Developments and Future Plans
Table 55. Global Colorectal Cancer Molecular Diagnostics Revenue (USD Million) by Players (2018-2023)
Table 56. Global Colorectal Cancer Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 57. Breakdown of Colorectal Cancer Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Colorectal Cancer Molecular Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Colorectal Cancer Molecular Diagnostics Players
Table 60. Colorectal Cancer Molecular Diagnostics Market: Company Product Type Footprint
Table 61. Colorectal Cancer Molecular Diagnostics Market: Company Product Application Footprint
Table 62. Colorectal Cancer Molecular Diagnostics New Market Entrants and Barriers to Market Entry
Table 63. Colorectal Cancer Molecular Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Colorectal Cancer Molecular Diagnostics Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Colorectal Cancer Molecular Diagnostics Consumption Value Share by Type (2018-2023)
Table 66. Global Colorectal Cancer Molecular Diagnostics Consumption Value Forecast by Type (2024-2029)
Table 67. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2023)
Table 68. Global Colorectal Cancer Molecular Diagnostics Consumption Value Forecast by Application (2024-2029)
Table 69. North America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Colorectal Cancer Molecular Diagnostics Raw Material
Table 100. Key Suppliers of Colorectal Cancer Molecular Diagnostics Raw Materials
List of Figures
Figure 1. Colorectal Cancer Molecular Diagnostics Picture
Figure 2. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type in 2022
Figure 4. Polymerase Chain Reaction PCR
Figure 5. Molecular Hybridization
Figure 6. Biochip
Figure 7. Others
Figure 8. Global Colorectal Cancer Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Third-Party Testing Agency Picture
Figure 12. Others Picture
Figure 13. Global Colorectal Cancer Molecular Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Colorectal Cancer Molecular Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Colorectal Cancer Molecular Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Region in 2022
Figure 18. North America Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Colorectal Cancer Molecular Diagnostics Revenue Share by Players in 2022
Figure 24. Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Colorectal Cancer Molecular Diagnostics Market Share in 2022
Figure 26. Global Top 6 Players Colorectal Cancer Molecular Diagnostics Market Share in 2022
Figure 27. Global Colorectal Cancer Molecular Diagnostics Consumption Value Share by Type (2018-2023)
Figure 28. Global Colorectal Cancer Molecular Diagnostics Market Share Forecast by Type (2024-2029)
Figure 29. Global Colorectal Cancer Molecular Diagnostics Consumption Value Share by Application (2018-2023)
Figure 30. Global Colorectal Cancer Molecular Diagnostics Market Share Forecast by Application (2024-2029)
Figure 31. North America Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 41. France Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 48. China Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 51. India Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Colorectal Cancer Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 65. Colorectal Cancer Molecular Diagnostics Market Drivers
Figure 66. Colorectal Cancer Molecular Diagnostics Market Restraints
Figure 67. Colorectal Cancer Molecular Diagnostics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Colorectal Cancer Molecular Diagnostics in 2022
Figure 70. Manufacturing Process Analysis of Colorectal Cancer Molecular Diagnostics
Figure 71. Colorectal Cancer Molecular Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
